跳至主要内容
临床试验/CTRI/2021/09/036128
CTRI/2021/09/036128尚未招募未知

Establishment and Validation of Urine Biomarkers before Prostate Biopsy: A Sequential-Enrollment, Blinded Study

Medicametrix0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Cohort randomized prospective study, signed informed consent, Male between age 45 AND 85 suspected case of prostate cancer (PCa) before biospy, Total PSA & Free PSA, 4K Score/PHI, Prostate volume, Testoterone, Routine urine analysis, Biochemical test, transrectal ultrasound (TRUS)-guided biopsies or DRE, MR Scan, microscopic anatomy, Gleason Score and estimates the overall â??Cancer Aggressivenessâ?? Score Sandwich Elisa.

排除标准

  • Patients come for second and third opinions, Unable to perform a Rectal Examination or any reason, Certain Lower Urinary Tract Congenital Abnormalities inability to understand or give informed consent, Patients with history of HIV, HBV, TB.

研究者

发起方
Medicametrix

相似试验

RINE BIOMARKER SCREENING FOR PROSTATE CANCER | 临床试验